Theme
Magnesium + vitamin B6 medicinal product · clinical use guardrails
Magne B6: correcting magnesium deficiency safely in adults and children 6+
For suspected or confirmed magnesium deficiency, dosing is age- and weight-based; renal function, levodopa, sugar content, pregnancy/lactation status and adverse effects materially change the risk–benefit assessment.
What it is for
Magne B6 is used to replenish magnesium deficiency. Symptoms compatible with deficiency may include neuromuscular, sleep, gastrointestinal or cardiovascular complaints; persistent or severe symptoms warrant medical evaluation.
High-risk exclusions
Renal contraindication
CrCl <30 ml/min: severe renal failure; do not use.Age restriction
<6 yrs contraindicated in children under 6 years.Drug interaction
Levodopa do not take together with Magne B6.Pediatric threshold
6+ yrs & >20 kg minimum label population for pediatric tablet dosing.How to take it: split daily dose with meals
| Population | Tablets/day | Elemental Mg/day | Vitamin B6/day | Administration |
|---|---|---|---|---|
| Adults | 6–8 | 288–384 mg | 30–40 mg | Divide into 2–3 doses, taken with meals. |
| Children >6 years and >20 kg | 4–6 | 192–288 mg | 20–30 mg | Divide into 2–3 doses, taken with meals. |
Daily magnesium and vitamin B6 totals are derived from the per-tablet content: 48 mg elemental magnesium + 5 mg pyridoxine vitamin B6.
Key finding 1 · recommended dose
6–8 tabs per day in adults; children over 6 years and >20 kg take 4–6 tablets/day. Divide into 2–3 doses with meals.Key finding 2 · do not use
CrCl <30 ml/min contraindicated in severe renal failure; also contraindicated in children under 6 years and with levodopa.Key finding 3 · formulation detail
115.6 mg sucrose per coated tablet; clinically relevant for diabetes counselling and rare sugar-intolerance syndromes.Who should avoid or use caution
Safety essentials
Numbers to know
Before use, read the patient information leaflet. If adverse effects occur, symptoms worsen, or deficiency symptoms persist, seek medical advice. This infographic supports clinical communication and does not replace local prescribing information.
AbbreviationsQuick
Bibliography1
- Листок-вкладыш – информация для пациента. Магне В6®, 48 мг+5 мг, таблетки, покрытые оболочкой; действующее вещество: магний + пиридоксин. Держатель регистрационного удостоверения: Opella Healthcare Commercial Ltd. Approved PIL-L, 26.12.2023.